Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Untangling the ATR-CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer.

Abdel-Fatah TM, Middleton FK, Arora A, Agarwal D, Chen T, Moseley PM, Perry C, Doherty R, Chan S, Green AR, Rakha E, Ball G, Ellis IO, Curtin NJ, Madhusudan S.

Mol Oncol. 2014 Nov 6. pii: S1574-7891(14)00262-2. doi: 10.1016/j.molonc.2014.10.013. [Epub ahead of print]

PMID:
25468710
[PubMed - as supplied by publisher]
2.

Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts.

Abdel-Fatah TM, Arora A, Alsubhi N, Agarwal D, Moseley PM, Perry C, Doherty R, Chan SY, Green AR, Rakha E, Ball G, Ellis IO, Madhusudan S.

Neoplasia. 2014 Nov 20;16(11):982-91. doi: 10.1016/j.neo.2014.09.009. eCollection 2014 Nov.

PMID:
25425972
[PubMed - in process]
Free PMC Article
3.

Targeting BRCA1-BER deficient breast cancer by ATM or DNA-PKcs blockade either alone or in combination with cisplatin for personalized therapy.

Albarakati N, Abdel-Fatah TM, Doherty R, Russell R, Agarwal D, Moseley P, Perry C, Arora A, Alsubhi N, Seedhouse C, Rakha EA, Green A, Ball G, Chan S, Caldas C, Ellis IO, Madhusudan S.

Mol Oncol. 2014 Aug 27. pii: S1574-7891(14)00183-5. doi: 10.1016/j.molonc.2014.08.001. [Epub ahead of print]

PMID:
25205036
[PubMed - as supplied by publisher]
4.

Is there a role for base excision repair in estrogen/estrogen receptor-driven breast cancers?

Abdel-Fatah TM, Perry C, Arora A, Thompson N, Doherty R, Moseley PM, Green AR, Chan SY, Ellis IO, Madhusudan S.

Antioxid Redox Signal. 2014 Dec 1;21(16):2262-8. doi: 10.1089/ars.2014.6077. Epub 2014 Sep 22.

PMID:
25111287
[PubMed - in process]
5.

Dissecting DNA repair in adult high grade gliomas for patient stratification in the post-genomic era.

Perry C, Agarwal D, Abdel-Fatah TM, Lourdusamy A, Grundy R, Auer DT, Walker D, Lakhani R, Scott IS, Chan S, Ball G, Madhusudan S.

Oncotarget. 2014 Jul 30;5(14):5764-81.

PMID:
25026297
[PubMed - in process]
Free PMC Article
6.

Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers.

Abdel-Fatah T, Arora A, Agarwal D, Moseley P, Perry C, Thompson N, Green AR, Rakha E, Chan S, Ball G, Ellis IO, Madhusudan S.

Breast Cancer Res Treat. 2014 Jul;146(2):309-20. doi: 10.1007/s10549-014-3035-2. Epub 2014 Jun 28.

PMID:
24972688
[PubMed - in process]
7.

Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial.

Middleton G, Silcocks P, Cox T, Valle J, Wadsley J, Propper D, Coxon F, Ross P, Madhusudan S, Roques T, Cunningham D, Falk S, Wadd N, Harrison M, Corrie P, Iveson T, Robinson A, McAdam K, Eatock M, Evans J, Archer C, Hickish T, Garcia-Alonso A, Nicolson M, Steward W, Anthoney A, Greenhalf W, Shaw V, Costello E, Naisbitt D, Rawcliffe C, Nanson G, Neoptolemos J.

Lancet Oncol. 2014 Jul;15(8):829-40. doi: 10.1016/S1470-2045(14)70236-0. Epub 2014 Jun 19.

PMID:
24954781
[PubMed - indexed for MEDLINE]
8.

Is there a role for second-line platinum re-challenge in advanced biliary tract cancers?

Adhikaree J, Madhusudan S.

Med Oncol. 2014 Jul;31(7):46. doi: 10.1007/s12032-014-0046-0. Epub 2014 Jun 10.

PMID:
24913810
[PubMed - in process]
9.

Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.

Abdel-Fatah TM, Russell R, Albarakati N, Maloney DJ, Dorjsuren D, Rueda OM, Moseley P, Mohan V, Sun H, Abbotts R, Mukherjee A, Agarwal D, Illuzzi JL, Jadhav A, Simeonov A, Ball G, Chan S, Caldas C, Ellis IO, Wilson DM 3rd, Madhusudan S.

Mol Oncol. 2014 Oct;8(7):1326-38. doi: 10.1016/j.molonc.2014.04.009. Epub 2014 May 13.

PMID:
24880630
[PubMed - in process]
10.

Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy.

Abbotts R, Jewell R, Nsengimana J, Maloney DJ, Simeonov A, Seedhouse C, Elliott F, Laye J, Walker C, Jadhav A, Grabowska A, Ball G, Patel PM, Newton-Bishop J, Wilson DM 3rd, Madhusudan S.

Oncotarget. 2014 May 30;5(10):3273-86.

PMID:
24830350
[PubMed - in process]
Free PMC Article
11.

Analysis of lymphatic and blood vessel invasion biomarkers in T1 esophagogastric adenocarcinomas for improved patient prognostication.

Perry C, Soomro I, Kaye P, Hardy E, Parsons SL, Ragunath K, Lobo DN, Martin SG, Madhusudan S.

Dis Esophagus. 2014 Feb 24. doi: 10.1111/dote.12190. [Epub ahead of print]

PMID:
24612464
[PubMed - as supplied by publisher]
12.

DNA repair in cancer: emerging targets for personalized therapy.

Abbotts R, Thompson N, Madhusudan S.

Cancer Manag Res. 2014 Feb 19;6:77-92. doi: 10.2147/CMAR.S50497. eCollection 2014. Review.

PMID:
24600246
[PubMed]
Free PMC Article
13.

SUMOylation proteins in breast cancer.

Alshareeda AT, Negm OH, Green AR, Nolan C, Tighe P, Albarakati N, Sultana R, Madhusudan S, Ellis IO, Rakha EA.

Breast Cancer Res Treat. 2014 Apr;144(3):519-30. doi: 10.1007/s10549-014-2897-7. Epub 2014 Mar 1.

PMID:
24584753
[PubMed - indexed for MEDLINE]
14.

Acute anterior uveitis as the presenting feature of Kawasaki disease.

Madhusudan S, Singh S, Suri D, Gupta A, Gupta A.

Indian J Pediatr. 2014 Apr;81(4):415. doi: 10.1007/s12098-014-1367-x. Epub 2014 Feb 25. No abstract available.

PMID:
24562721
[PubMed - in process]
15.

DNA polymerase β deficiency is linked to aggressive breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression in multiple cohorts.

Abdel-Fatah TM, Russell R, Agarwal D, Moseley P, Abayomi MA, Perry C, Albarakati N, Ball G, Chan S, Caldas C, Ellis IO, Madhusudan S.

Mol Oncol. 2014 May;8(3):520-32. doi: 10.1016/j.molonc.2014.01.001. Epub 2014 Jan 10.

PMID:
24462520
[PubMed - indexed for MEDLINE]
16.

Dysregulation of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in advanced retinoblastoma.

Sudhakar J, Khetan V, Madhusudan S, Krishnakumar S.

Br J Ophthalmol. 2014 Mar;98(3):402-7. doi: 10.1136/bjophthalmol-2013-304166. Epub 2014 Jan 2.

PMID:
24385289
[PubMed - indexed for MEDLINE]
17.

Clinicopathological significance of human apurinic/apyrimidinic endonuclease 1 (APE1) expression in oestrogen-receptor-positive breast cancer.

Abdel-Fatah TM, Perry C, Moseley P, Johnson K, Arora A, Chan S, Ellis IO, Madhusudan S.

Breast Cancer Res Treat. 2014 Feb;143(3):411-21. doi: 10.1007/s10549-013-2820-7. Epub 2014 Jan 1.

PMID:
24381055
[PubMed - indexed for MEDLINE]
18.

Electrocautery interference with intraoperative capnography during neurosurgery.

Surve R, Madhusudan S, Sriganesh K.

J Clin Monit Comput. 2014 Aug;28(4):429-30. doi: 10.1007/s10877-013-9546-2. Epub 2013 Dec 19. No abstract available.

PMID:
24352380
[PubMed - indexed for MEDLINE]
19.

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial.

Ford HE, Marshall A, Bridgewater JA, Janowitz T, Coxon FY, Wadsley J, Mansoor W, Fyfe D, Madhusudan S, Middleton GW, Swinson D, Falk S, Chau I, Cunningham D, Kareclas P, Cook N, Blazeby JM, Dunn JA; COUGAR-02 Investigators.

Lancet Oncol. 2014 Jan;15(1):78-86. doi: 10.1016/S1470-2045(13)70549-7. Epub 2013 Dec 10.

PMID:
24332238
[PubMed - indexed for MEDLINE]
Free Article
20.

Single-strand selective monofunctional uracil-DNA glycosylase (SMUG1) deficiency is linked to aggressive breast cancer and predicts response to adjuvant therapy.

Abdel-Fatah TM, Albarakati N, Bowell L, Agarwal D, Moseley P, Hawkes C, Ball G, Chan S, Ellis IO, Madhusudan S.

Breast Cancer Res Treat. 2013 Dec;142(3):515-27. doi: 10.1007/s10549-013-2769-6. Epub 2013 Nov 20.

PMID:
24253812
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk